Ajanta Pharma Limited (BOM:532331)

India · Delayed Price · Currency is INR

2,990.90

+16.40 (0.55%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Pharmaceuticals	46.48B	42.09B	37.43B	33.41B	28.90B
Pharmaceuticals Growth	10.44%	12.45%	12.02%	15.62%	11.66%
Total	46.48B	42.09B	37.43B	33.41B	28.90B
Total Growth	10.44%	12.45%	12.02%	15.62%	11.66%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
India	14.52B	13.08B	11.74B	9.82B	8.13B
India Growth	11.07%	11.39%	19.53%	20.82%	5.75%
Africa	1.47B	2.49B	1.90B	2.06B	2.71B
Africa Growth	-40.99%	30.68%	-7.70%	-24.01%	10.97%
United States	10.47B	9.64B	8.28B	6.96B	6.37B
United States Growth	8.69%	16.40%	18.96%	9.27%	23.54%
Emerging Market	19.41B	16.42B	15.16B	14.00B	11.24B
Emerging Market Growth	18.24%	8.33%	8.25%	24.53%	9.15%
Total	45.88B	41.62B	37.08B	32.84B	28.45B
Total Growth	10.23%	12.25%	12.89%	15.43%	11.20%

Source: S&P Global Market Intelligence.